Search
Now showing items 1-6 of 6
Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same
(United States. Patent and Trademark Office, 2020-06-16)
Vaccine compositions including a yeast comprising an immunostimulatory polypeptide and optionally an antigenic polypeptide are provided herein. The immunostimulatory polypeptide and the antigenic polypeptide are expressed ...
Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection
(United States. Patent and Trademark Office, 2020-10-06)
Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
Compositions and methods of enhancing immune responses to enteric pathogens
(United States. Patent and Trademark Office, 2020-07-21)
Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be ...
Compositions and methods of enhancing immune responses to enteric pathogens
(United States. Patent and Trademark Office, 2021-05-25)
Vaccine vectors capable of eliciting an immune response to enteric bacteria and methods of using the same are provided. The vaccine vectors include a polynucleotide encoding a PAL polypeptide. The PAL polypeptide may be ...
Yeast Vaccine Vector Including Immunostimulatory And Antigenic Polypeptides And Methods Of Using The Same
(United States. Patent and Trademark Office, 7/12/2022)
Vaccine compositions including a yeast comprising an immunostimulatory polypeptide and optionally an antigenic polypeptide are provided herein. The immunostimulatory polypeptide and the antigenic polypeptide are expressed ...
Compositions And Methods Of Enhancing Immune Responses To Eimeria Or Limiting Eimeria Infection
(United States. Patent and Trademark Office, 6/21/2022)
Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...